1 January 2019 in Annals of Vascular Surgery
1 January 2011 in Journal of the Korean Surgical Society
Yoon KW, et al. J Korean Surg Soc. 2011 Dec;81(6):394-401. http://dx.doi.org/10.4174/jkss.2011.81.6.394
1 January 2017 in Annals of Surgical Treatment and Research
Han HS, et al. Ann Surg Treat Res. 2017 Sep;93(3):143-151. https://doi.org/10.4174/astr.2017.93.3.143
1 January 2023 in Annals of Surgical Treatment and Research
Kim S, et al. Ann Surg Treat Res. 2023 Feb;104(2):119-125. https://doi.org/10.4174/astr.2023.104.2.119
1 February 2020 in Transfusion and Apheresis Science
31 December 2016 in Vascular Specialist International
The superiority of autogenous vein conduits is well known in lower extremity arterial bypass (LEAB). Among various alternative conduits for LEAB, long-term results of arm vein grafts were investigated in this study. We retrospectively reviewed clinical characteristics of 28 patients who underwent infrainguinal LEAB with autogenous arm vein grafts at a single institute between January 2003 and December 2015. All procedures were performed in the absence of adequate saphenous veins. Graft patency was determined by periodic examinations with duplex ultrasonography. Autologous arm vein grafts were implanted for 28 patients (mean age, 60.4±16.8 years; range, 20-82 years; male, 92.9%; atherosclerosis, 19 [67.9%]; and non-atherosclerotic disease 9 [32.1%] including 5 patients with Buerger's disease). Source of arm vein were basilic 13 (46.4%), cephalic 4 (14.3%) and composition graft with other veins in 11 (39.3%) cases. The level of distal anastomosis was distributed as popliteal in 5 (17.9%), tibio-peroneal in 21 (75.0%) and inframalleolar artery in 2 (7.1%) cases. Mean duration of follow-up was 41.5±46.9 months (range, 1-138 months). Cumulative primary patency rates at 1, 3, and 5 years were 66.5%, 60.9% and 60.9%, respectively. Assisted-primary patency rates at 1, 3 and 5 years were 66.5%, 66.5% and 66.5%, respectively. Secondary patency rates at 1, 3 and 5 years were 70.8%, 70.8% and 70.8%, respectively. There was one limb amputation during the follow-up period. Arm veins are a useful alternative conduit when great saphenous veins are not available during LEAB.